BioPharma Pharma & Biopharma Manufacturing

YolTech Partners with KACTUS to Commercialize Breakthrough DNA Editor YolCas12TM in Greater China

YolTech, a clinical-stage biopharmaceutical company specializing in mRNA-LNP delivery for in vivo gene editing therapies, has partnered with KACT...

 June 19, 2024 | News

FDA Clears Zymeworks' ZW171 for Mesothelin-Expressing Cancers

  “We are excited to reach this R&D milestone with ZW171, reflecting our commitment to advancing innovative therapies for cancer treatment,...

 June 18, 2024 | News

Ascentage Pharma Secures $1.3 Billion Deal with Takeda for Global Rights to Olverembatinib

Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas. ...

 June 17, 2024 | News

Ethypharm Expands Portfolio with Acquisition of Mesalazine Suppository by Chinese Affiliate

Ethypharm is pleased to announce the acquisition of a suppository form of Mesalazine by its Chinese affiliate, Shanghai Ethypharm Pharmaceuticals Ltd, from...

 June 14, 2024 | News

Bespak Expands Low GWP Inhaler Production with New High-Speed Filling Equipment

Bespak, a leading contract development and manufacturing organisation (CDMO) focused on orally inhaled and nasal drug-device combination products, is today...

 June 12, 2024 | News

Freudenberg Medical Invests Over $50 Million in New Hemoteq Production Facility in Germany

Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry with facilities in key industry...

 June 12, 2024 | News

Aragen Bioscience and Getinge Validate Single-Use Production Reactors for Large-Scale Recombinant Antibody Production

Aragen Bioscience, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, and Getinge, a Swedish...

 June 05, 2024 | News

HuidaGene Therapeutics and Synthego Corporation Forge Licensing Agreement for Advanced CRISPR Nuclease

HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company focused on advancing CRISPR-based genomic medicines, and Synthego Corpo...

 May 31, 2024 | News

Takara Bio Inc. Launches Large-Scale Viral Vector Manufacturing with Thermo Fisher’s DynaDrive Bioreactors

Thermo Fisher Scientific in Japan is pleased to announce that, as of 22 April 2024, Takara Bio Inc. has begun large-scale viral vector contract manufacturi...

 May 30, 2024 | News

Cytiva Launches Sefia: Advanced Platform to Transform CAR T Cell Therapy Manufacturing

Sefia cell therapy manufacturing platform comes out of Cytiva's extensive R&D expertise and in-depth understanding of CAR T manufacturing Automation...

 May 30, 2024 | News

Eli Lilly Doubles Investment in Indiana Manufacturing Site with New $5.3 Billion Commitment

Eli Lilly and Company announced  that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 bi...

 May 28, 2024 | News

Merck Acquires Mirus Bio for $600 Million to Strengthen Viral Vector Manufacturing Capabilities

Acquisition will advance Merck’s integrated offering for viral vector manufacturing Complements existing portfolio for development and production ...

 May 23, 2024 | News

Touchlight Genetics and NPL Receive Innovate UK Funding for Advanced Gene Therapy Technology

Touchlight Genetics, in partnership with the National Physical Laboratory (NPL) have secured funding from Innovate UK under their Innovative Technologies: ...

 May 13, 2024 | News

Ribobay Pharma Partners with Cytiva to Launch Pioneering Oligonucleotide Manufacturing Platform in China

Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO) and a spin-off company of Genera...

 May 09, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close